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N-isopropylacrylamide (NiPAAm), acrylamide (AAm), N, N-
methylenebisacrylamide (MBAAm) and TRITC-dextran (20, 65-85 and 155 kDa) were 
purchased from Sigma-Aldrich. AlexaFluor-dextran 680 (10kDa) was purchased from 
Invitrogen. The photoinitiator 2-hydroxy-2-methyl-1-phenyl-propan-1-one (Darocur-1173) 
was purchased from Ciba® and polydimethylsiloxane (PDMS) Sylgar 184 from Dow 
Corning®. All aqueous solutions were prepared using deionized water. All chemicals were of 
analytical reagent grade and were used as received without any further purification. 
 
 
Fabrication of gel and capsule 
 
NiPAAm-co-AAm gels were fabricated by UV photo-polymerization. An schematic 
of the fabrication process is shown in Figure 1. Briefly, the pre-polymer solution mixture, 
containing NiPAAm (1.7 M, 20% w/w), the co-monomer AAm (85:15 molar 
NiPAAm:AAm), the crosslinker MBAAm (5 % w/w respect NiPAAm monomer) and the 
photoinitiator Daracour 1173 ® (0.1 % w/w) dissolved in water:ethanol (50:50 v/v), was 
placed inside a PDMS container and covered with a glass slide. A photo-mask transparency 
with the desired design was placed over the glass slide and the photo-polymerization was 
initiated by irradiating with UV light (350 nm) (Omnicure series 2000, Lumen Dynamics 
Group Inc., Canada). The polymerization was completed within 48 seconds resulting gels, 
that in water at room temperature, were discs of 7.2  0.08 mm in diameter and 1.55  0.06 
mm in thickness. Then, the hydrogels were rinsed thoroughly with water to remove the non-
crosslinked pre-polymer and allowed to swell to equilibrium at room temperature in 
deionized water for 24h. 
  
To load the fluorophore labeled dextran inside the gels, first the gels were dried at 
room temperature for 24 h.  Next, the dry gels were allowed to swell in a concentrated 
solution of dextran (200 M) for a day.  Finally, the loaded-gels were dried again for 48 h 
and kept in the fridge until use.  In order to minimize the diffusion of the dextran from inside 
the NiPAAm:AAm gel to the surrounding media, and have a better control over the pulsatile 
release, the gels were encapsulated inside a containers made of PDMS [16]. The latter were 
designed to exactly fit the dimensions of the gels at 37ºC (6.6  0.07 mm in diameter and 1.5 
 0.08 in thickness in water and 5.2  0.1 mm in diameter and 1.3  0.07 in PBS buffer); and 
therefore minimize non-desired dextran leaks. The PDMS capsules were fabricated by replica 
molding of a polyacrylamide master. First, the PDMS elastomer base and the curing agent 
were mixed at ratio 10:1 w/w and poured over the master. After degassing the solution in a 
vacuum chamber the PDMS was cured at 70ºC for 30 min. Then, the cured PDMS was 
peeled-off from the master, and the dried loaded-NiPAAm-co-AAm gel placed inside the 
cavity and irreversibly bonded to a PDMS coverlid using oxygen plasma. The PDMS 
coverlid was pierced twice with a 30-gauge needle before the bonding step to open the two 
apertures of the capsule. After the bonding the capsule was filled with deionized water or 
PBS buffer using a syringe and in less than 30 minutes the NiPAAm-co-AAm gels swollen to 
occupy the entire chamber volume blocking the releasing holes. 
 
Characterization of gel contraction with temperature 
Gels of different compositions (NiPAAm:AAM ratios ranging from 100:0 to 80:20 
and amount of crosslinked, MBAAB, ranging from 5% to 15%) were fabricated as described 
above; and its thermal response characterized over a range of temperature from 20ºC to 50ºC. 
Each gel was immersed for at least 60 minutes (to ensure equilibrium) in a water bath at 
different temperature set points. Then, gels were carefully transferred to a microscope slide 
and an optical image was taken using an optical microscope with an integrated camera. The 
gel dimensions were measured using a measuring tool from the microscope software.  The 
change of gel dimensions with temperature was represented as a relative diameter change to 
its dimensions at room temperature (see Figure 2a and 2b).  
 
Quantification of gel loading capacity 
Gels were loaded by swelling from its dry form in a concentrated solution of dextran 
(200 M).  To quantify the amount of labeled dextran loaded in the gel, the latter was 
immersed in a clean water bath (1 mL) and the dextran was allowed to diffuse out form the 
gel matrix. Every 2 hours the gel was transferred to a clean water bath and the levels of 
dextran released from the gel quantified by fluorescence. This process was repeated until no 
dextran was detected in the baths. The sum of the amount of dextran released in all the baths 
corresponds to the amount of dextran loaded in the gel.  
Figure 2e summaries the amount of dextran loaded per gel using different molecular 
weights of dextran. 
 
 
Characterization of gel capsules in vitro 
 
For contraction of the NiPAAM-co-AAM gels using a conventional thermal bath, the 
devices loaded with 54.7  6.8 g TRITC-dextran (20kDa) were individually immersed in 
small containers filled with 3 mL of deionized water at 37ºC for at least 45 minutes. To 
contract the gel, the device was transferred to a second container set at 45ºC. Every 3 to 5 
minutes, 200 L of water were removed from the container to quantify the amount of 
TRITC-dextran released and replaced with 200 L of fresh water.  The water baths and the 
gels temperature were monitored in real time using two thermocouples (HYPO-33-1-T-G-60-
SMPW-M, Omega) connected to a digital thermometer (HH506RA, Omega).  The total 
amount of dextran released was quantified by analyzing the different water bath solution with 
fluorescence.  
 
 For the FUS-induced release experiments, we used a high-intensity ultrasound 
spherically sectioned transducer with a center frequency 1.525 MHz, focal length of 90 mm, 
and an aperture radius of 40 mm. The FUS transducer also had a central aperture containing a 
coaxial diagnostic A-scan transducer (center frequency 7.5MHz, focal length 60 mm). The 
foci of the two transducers were co-aligned. The diagnostic transducer was used to produce 
B-mode images of the gels and provide guidance to align the FUS focal point into the gel (see 
Figure 2-c). A plastic truncated-cone shell was attached to the transducer, filled with 
degassed water and its end covered with a thin membrane. The truncated end of the cone was 
approximately 25 mm less than the radius of curvature of the transducer, i.e., the acoustic 
energy was focused 25 mm in front of the truncated cone. A thick piece of gel phantom 
(Aqualfex, Parker Laboratories) was used to adjust the focal distance and facilitate 
transmission of acoustic energy. Acoustic-coupling gel was also used to provide a good 
coupling during the scans. 
Although originally the FUS transducer was designed for thermal therapy using high-
intensities (HIFU), for these experiments it was operated at moderate intensities (<500	
W/cm2). This transducer was driven by a function generator (Model 33250A, Aglient) in 
combination with a RF power amplifier (Model A150, ENI). For our experiments, the pre-
amplified driving voltage ranged between 70 and 300 mV. The focal acoustic intensity of the 
transducer was characterized using radiation-force-balance method described in previous 
studies [PC6,PC7]. This method relies of measurement of acoustically induced force acting 
on an sound-absorbing target placed on a scale. We operated the transducer in the third 
harmonic mode to measure the acoustically exerted force on a sound-absorbing target placed 
on a scale. The precision of the scale was not adequate for reproducible and accurate 
measurements of acoustically induced force when the transducer was operated at driving 
voltages below 400 mV. We measured the intensity over a wide range (100-1000 mV) to 
include regime where our setup provided reliable measurements. Force measurements 
acquired using the scale were then used to estimate the focal intensities (P = 
2Fc/(cos(1)+cos(2))/DF; I = P/A) at each driving voltage. P is acoustic power, F is 
measured force, c is sound speed, 1 and 2 are half angles corresponding to transducer hole 
and diameter, respectively, DF is the duty factor, I is intensity, and A is cross-sectional area 
of the FUS beam along the focal plane. The intensity values were divided by nine to obtain 
estimates of focal intensity produced by the transducer when operating at the fundamental 
frequency (Fig. S1). Based on these measurements, the focal intensities necessary to 
thermally actuate the hydrogel-based devices were below 500 W/cm2. 
	
Figure S1.  Focal acoustic intensity of the FUS transducer estimated using a 
radiation-force balance. 
	
For the FUS experiments, the PDMS capsule (containing the loaded gel) was fixed at 
the bottom of a bigger PDMS container filled with deionized water at 37ºC. The PDMS 
container was then covered with a thin layer of PDMS (0.5 mm), a 1.5 mm thick gel 
phantom (Aquaflex, Parker Laboratories) and acoustic-coupling gel. The application of FUS 
resulted in local heating from 37ºC to 45ºC, inducing the release of dextran from the gel. The 
temperature in the gel was sustained to 45  0.5ºC for all the duration of the experiment 
(between 2 and 15 minutes) by turning the FUS ‘on’ and ‘off’ using a temperature reading 
feedback loop from a thermocouple inserted in the gel. The feedback loop was implemented 
using a PC-based instrumentation‐control	software,	which	recorded	and	monitored	the	
thermocouple	temperature	and	also	controlled	the	function	generator	used	for	driving	
the	FUS	transducer.	The	control	software	turned	off	the	signal	output	of	the	function	
generator	when	the	in	situ	temperature	exceeded	45.5ºC. Conversely, the control software 
turned the signal output back on when the temperature decreased to a value less than 44.5ºC. 
At the end of each experiment, the FUS was turned ‘off’ and the temperature in the gel 
immediately dropped from 45ºC back to 37ºC stopping the FITC-dextran release. The 
temperature in the hot plate set at 37ºC was stable for 10 minutes at 37.3 ± 0.3ºC (data not 
shown). 
  For all in vitro experiments, the amount of TRITC-dextran released from the gel to 
the surrounding media was analyzed by fluorescence (ex = 540 nm, em = 580 nm) using a 
plate reader (Cinergy 4, Biotech). TRITC-dextran concentrations were calculated in 




Simulation of FUS-induced heating 
 
An open source package for linear simulation of ultrasound propagation in tissue, Fast 
Object- oriented C++ Ultrasound Simulator (FOCUS) [1, 2], was employed to calculate the 
acoustic-pressure field generated by the FUS transducer when operated at 1.5 MHz. The 
primary goal of the simulation study was to verify that the fixed-focus FUS transducer could 
provide localized heating in a region that corresponded to the location and the size of our 
devices. Due to the axi-symmetric nature of the acoustic field produced by a spherically 
sectioned transducer, acoustic-pressure calculations were performed on a 2D grid that was 20 
mm in the scan direction and 40 mm in the acoustic direction and centered around the focus 
of the FUS transducer (denoted by the green * in Fig. S1). Inter-nodal spacing in the 
computation grid was /12, where  was the acoustic wavelength. FOCUS discretizes the 
acoustic source, i.e., the FUS transducer in this case, into apodized rectangles and employs 
super-position of time-harmonic numerical calculations of the pressure response from 
individual rectangular pistons.  
 Figure S2.  Simulation of spatial distribution of acoustic power delivered to tissue 
using the FUS transducer.   
The pressure field p(r) was then used as input to determine the spatial distribution of 
the acoustic power delivered to the tissue, which is given by the following equation: 
ܳሺݎሻ ൌ ఈఘ௖ ∑ ݌ሺݎ, ݐሻ݌∗ሺݎ, ݐሻ,     (1) 
where  is absorption coefficient,  and c represent the density and sound speed of 
the medium, respectively, and the superscript * represents conjugate transpose. The acoustic 
power deposition was used as an input for the steady-state bio-heat equation given by 
ܭ׏ଶܶሺݎሻ െ ௕ܹܥ௕ܶሺݎሻ ൅ ܳሺݎሻ ൌ 	0,    (2) 
where K is the thermal conductivity of tissue, Cb is the specific heat of blood, Wb is 
the blood perfusion rate, T is the temperature increase in tissue. In this equation, the first and 
the third terms describe heat accumulation at any point in the computation grid resulting from 
thermal conduction and acoustic-energy deposition, respectively. The second term describes 
the convective heat loss (an effective heat-sink) associated with blood perfusion. Equation 2 
is solved with an iterative finite-difference scheme to simulate FUS-induced heating and its 
solution (T(r)) predicts the temperature distribution resulting from sonication. FOCUS allows 
user to input the amplitude of the acoustic pressure at the transducer face. This value was 
chosen such that a lateral extent of 45°C region was achieved in a region that was 1-mm wide 
in the scan direction. The	 tissue	 volume	 that	 reached	 45°C	 was	 contained	 within	 the	
NiPAAm	device	(Fig.	4A,	green	dashes)	in	the	lateral	(scan)	direction	but	exceeded	the	
device	dimension	in	the	axial	(acoustic)	direction. 
PDMS‐only	 disks.	 	 	 Disks	 made	 only	 of	 PDMS	 were	 studied	 to	 show	 the	
ultrasound	thermometry	was	based	only	on	PDMS. 
Ultrasound	thermometry.		For thermometry, because the thermocouple was oriented 
orthogonally to this cylinder, careful alignment of the thermocouple with the focus of the 
FUS transducer was critical to accurate temperature assessment. In some instances, errors in 
aligning the focus of the FUS transducer with the thermocouple tip resulted in a 
thermocouple reading that was lower than the true temperature at the focus and consequently, 
more time was needed for thermocouple to reach the set-point temperature. To achieve a 
good alignment, the thermocouple was always inserted to the center of the gel and B-mode 
ultrasound images of the device were used to align the FUS focal volume to the center of the 
gel. For all experiments that required more than 60 seconds to reach 45ºC at the 
thermocouple tip, the FUS transducer was considered to be misaligned with the thermocouple 
the results were excluded. 
 
 
FUS triggering in tissue 
 
For the ex vivo tissue experiments we used the same FUS transducer described above 
with the only difference that a longer water-filled conical section was mounted to its housing 
(to couple ultrasonic energy into hydrogel structures or tissue). The end of this cone was 5 
mm less than the transducer focal distance, so a gel placed under a 5 mm layer of tissue was 
perfectly placed at the FUS focal point; eliminating the need of using gel phantoms or 
Aquaflex pads to adjust the focal distance. Acoustic-coupling gel was used to facilitate 
transmission of acoustic energy into the tissue. 
  
To add an imaging modality, the ultrasound apparatus shown in Figure 3-a also 
included an A-mode imaging transducer co-axially located in the center hole of the FUS 
transducer. This transducer had a focal length of 60 mm, a center frequency of 7.5 MHz, and 
a bandwidth of 4 MHz. 
  
These experiments mimicked the conditions of a device implanted subcutaneously in 
mice and evaluate the feasibility of the FUS thermal-actuation. For this reason the devices 
were sandwiched between a layer of mouse skin on the top and a piece of chicken tissue in 
the bottom. The devices were placed with the apertures facing down (towards the chicken 
tissue), so the dextran release took place in the same direction that the ultrasound. The 
geometric focus of the transducer was manually aligned with the implant using the 
ultrasound-echo signal obtained from the diagnostic transducer. During the localized heating 
of the implant, the FUS transducer was operated in a quasi- continuous wave (CW) mode (<1 
kW/cm2) and the diagnostic transducer in pulse-echo mode at a PRF of 100 Hz to perform 
noninvasive thermometry (pulser-receiver system, Model 5052PR, Panametrics). Local 
temperature change was inferred from the thermally induced change in sound speed and 
consequently in a time-shift of the echo signal. The noninvasively obtained local temperature 
was used as a feedback to modulate the FUS amplitude for maintaining the temperature of the 
implant at 45 ± 0.5 ºC. 
  
For the ex-vivo experiments AlexaFluor-dextran 680 (10 kDa) was used as a drug 
substitute to be released from the NipAAm capsules. AlexaFluor 680 was chosen because it 
has an excitation wavelength of 679 nm and an emission wavelength of 702 nm; making it 
very suitable to obtain good quality fluorescent images as at those wavelengths the auto-
fluorescent background from tissue is minimal. 
 
Animal experiments 
 One sterile device was implanted subcutaneously in the dorsum of 8 male athymic 
nude mice (NCr nude, Taconic) under isoflurane anesthesia. The incision (2cm) was closed 
using surgical staples and liquid pockets were created around the device injecting PBS saline 
buffer.  During FUS actuation and in-vivo imaging, the mice were anaesthetized using 
isoflurane, so the animals did not have to be restrained. All animals were at least for a week 
before surgery on alfalfa-free diet (Teklad Global Diet, 2914) to minimize autofluorescent 
signals from the digestive track in the far-red range during in vivo imaging. All animal 
procedures were performed in accordance with approved Institutional Animal Care and Use 
Committee protocols. 
 For histological studies, the PDMS capsules were implanted for 2 and 4 weeks for the 
H&E and Trichrome analysis without FUS treatment.  Tissue samples were excised at the 
time of device explant and stored in 10% buffered formalin for 24 hours prior to analysis. 
One cross perpendicular sections passing through the center of the tissue sample was taken 
and embedded in paraffin. Histologic slides were prepared and stained with hematoxylin and 
eosin (H&E), trichrome or TUNEL assay.  Using the same segmentation thresholds for FUS-
treated and control images, percentage of apoptotic cells was determined as the ratio of 
number of pixels representing apoptotic cells over total cell-related pixels.   
 Figure S3.  Histology of mouse skin after implantation of iTAG and FUS actuation. Excised 
skin from the mouse was stained with hematoxylin and eosin (A) as well as trichrome (B). 
Histological analysis revealed minimal presence of giant body cells indicating the lack of 
chronic inflammation. A thin fibrous capsule (<1mm) was also present indicating normal 
wound healing. The asterisk (*) indicates the location of the device in vivo  
 
